Ilenia Calcaterra: Impact of Pain on Severe Haemophilia A Patients Receiving Emicizumab Prophylaxis
Ilenia Calcaterra, Researcher at University of Naples Federico II, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Haemophilia, adding:
”I am pleased to share our new publication in Haemophilia:
‘Use of the Multidimensional Haemophilia Pain Questionnaire (MHPQ) in Patients With Severe Haemophilia A Treated With Emicizumab: A Pilot Cross-Sectional, Single-Centre Study’
In this pilot study, we used the Multidimensional Haemophilia Pain Questionnaire (MHPQ) to assess the prevalence, characteristics, and functional impact of pain in adults with severe haemophilia A receiving Emicizumab prophylaxis.
Despite effective bleed control, pain remained a clinically relevant burden: 77.8% of patients reported pain within the previous 12 months, most commonly involving the ankles and knees, with an impact on daily activities, walking ability, mood, and enjoyment of life.
These findings suggest that, in the non-factor prophylaxis era, haemophilia-related pain is not exclusively bleeding-driven, but reflects a more complex and multidimensional phenotype.
Integrating structured pain assessment tools into routine haemophilia care may help better identify patients’ needs and support more personalized, multidisciplinary management strategies.
My sincere thanks to all co-authors, patients, and patient associations who continue to support clinical research in haemophilia.”
Title: Use of the Multidimensional Haemophilia Pain Questionnaire (MHPQ) in Patients With Severe Haemophilia A Treated With Emicizumab: A Pilot Cross-Sectional, Single-Centre Study
Authors: Ilenia Lorenza Calcaterra, Sofia Donnarumma, Guido D’Errico, Carmine De Luca, Chiara Caputo, Paola Ciciola, Ernesto Cimino, Matteo Di Minno

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 02:38Brianne D.: Sex Differences in RIPK1 Signaling Following Intracerebral Hemorrhage
-
Oct 10, 2026, 02:17Dino Mehic: Managing Heavy Menstrual Bleeding in Patients with BDUC
-
Oct 10, 2026, 00:34Raphaëlle Dodart: Discussing the Mechanisms of Menstrual Hemostasis
-
Oct 10, 2026, 00:26Barbara Adams Krolak: Discussing the Growing Need for Blood Clot Prevention in Asia
-
Oct 9, 2026, 23:59Ana Pedrero Gil: Is Coagulopathy with Fibrinolysis Present in All Obstetric Hemorrhages?
-
Oct 9, 2026, 23:57Exploring the Psychosocial Needs of People with Bleeding Disorders in Kyrgyzstan – EAHAD
-
Oct 9, 2026, 23:53Bernard Slater Jr.: Serving on the Advisory Council for the NBDF West Virginia Chapter
-
Oct 9, 2026, 23:53Aurelio Maggio: Thalassemia Reports Real-Time Impact Factor Rises to 1.760
-
Oct 9, 2026, 23:52Stronger Connections, Stronger Organizations – World Federation of Hemophilia